Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 3,539,000 $ 516,000
Cost of revenue:    
Cost of revenue 3,524,000 516,000
Provision for contract losses 33,737,000 0
Total cost of revenue 37,261,000 516,000
Gross loss (33,722,000) 0
Operating expenses:    
Selling, general, and administrative 20,395,000 2,152,000
Research and development 9,605,000 1,608,000
Total operating expenses 30,000,000 3,760,000
Operating loss (63,722,000) (3,760,000)
Interest income, net 194,000 40,000
Gain (loss) on warrant remeasurement 4,026,000 (303,000)
Other expense, net (76,000) (33,000)
Net loss before taxes (59,578,000) (4,056,000)
Income tax benefit 610,000 0
Net loss (58,968,000) (4,056,000)
Other comprehensive loss, net of taxes    
Unrealized losses on available-for-sale securities (379,000) (12,000)
Cumulative translation adjustment (1,000) 0
Total comprehensive loss $ (59,348,000) $ (4,068,000)
Loss per share    
Loss per share – Basic (in dollars per share) $ (0.32) $ (0.42)
Loss per share – Diluted (in dollars per share) $ (0.32) $ (0.42)
Weighted average number of shares outstanding – Basic 184,031,015 9,763,675
Weighted average number of shares outstanding – Diluted 184,031,015 9,763,675